Circulating tumor DNA as a biomarker to guide therapy in post-operative locally advanced rectal cancer: the best option?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circulating tumor DNA as a biomarker to guide therapy in post-operative locally advanced rectal cancer: the best option?

Published:2017-10-06 Issue:1 Volume:18 Page:1-3
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Tie Jeanne¹²³⁴,Semira Christine¹,Gibbs Peter¹²³⁴

Affiliation:

1. Division of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

2. Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia

3. Department of Medical Oncology, Western Health, Melbourne, Australia

4. Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia

Funder

funded

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737159.2018.1386558

Reference16 articles.

1. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

2. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

3. Circulating mutant DNA to assess tumor dynamics

4. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

5. Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential role of minimal/molecular residual disease in colorectal cancer: curative surgery, radiotherapy and beyond;Journal of the National Cancer Center;2023-09

2. Clinical Perspectives in the Use of Liquid Biopsy in Metastatic Breast Cancer;Circulating Tumor Cells;2023

3. Machine learning identifies two autophagy-related genes as markers of recurrence in colorectal cancer;Journal of International Medical Research;2020-10

4. A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer;BMC Cancer;2020-08-28

5. Liquid Biopsy for Cancer: Review and Implications for the Radiologist;Radiology;2020-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3